PlainRecalls
FDA Drug Moderate Class II Terminated

Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reported: September 28, 2016 Initiated: August 24, 2016 #D-1513-2016

Product Description

Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reason for Recall

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Details

Recalling Firm
Sandoz Inc
Units Affected
32,099 cartons
Distribution
Nationwide and Puerto Rico
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.. Recalled by Sandoz Inc. Units affected: 32,099 cartons.
Why was this product recalled?
Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 28, 2016. Severity: Moderate. Recall number: D-1513-2016.